Idexx Laboratories Inc Revenue per Employee (IDXX), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Idexx Laboratories Inc  (NASDAQ: IDXX)
 

Idexx Laboratories Inc's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 9.95% in the third quarter 2026, year on year to cumulative value of $4,664 million, Idexx Laboratories Inc's revenue per employee grew on a trailing twelve months basis to $ 423,970. The productivity of Idexx Laboratories Inc's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 235 other companies have achieved higher revenue per employee. While Idexx Laboratories Inc's total ranking has deteriorated compared to the previous quarter from 795 to 1917. Idexx Laboratories Inc has 11,000 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

IDXX Revenue per Employee (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Revenue Change 9.95 % 9.73 % 14.26 % 14.4 % 13.26 %
Sales per Employee (TTM) $ 423,970 413,981 404,176 391,234 378,739
IDXX's Total Ranking # 1917 # 795 # 877 # 625 #
Seq. Revenue Change -0.19 % 6.65 % 4.45 % -1.11 % -0.39 %

IDXX Company Profile >> Back to IDXX Efficiency Comparisons >> Compare IDXX Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry # 3
Healthcare Sector # 236
Overall Market # 1917

Revenue per Employee Statistics
High Average Low
$ 404,176 $ 228,761 $ 125,187
(Mar 31 2026)   (Dec 31 2013)



Financial Statements
Idexx Laboratories Inc's Revenue MRQ $ 1,214 Millions Visit IDXX's Income Statement
Idexx Laboratories Inc's Revenues TTM $ 4,664 Millions Visit IDXX's aggregate revenue growth
What are IDXX's Sales? Visit IDXX's Sales by Segment




Other Ratios
Idexx Laboratories Inc's Income per Employee
Employees in In Vitro & In Vivo Diagnostic Substances
In Vitro & In Vivo Diagnostic Substances Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
IDXX's Revenue per Employee versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for IDXX's Competitors
Revenue per Employee for IDXX's Suppliers
Revenue per Employee for IDXX's Customers

You may also want to know
IDXX's Sales Growth Rates IDXX's Pe Price to earnings ratio IDXX's Receivables Turnover Ratio IDXX's Stock Quote
IDXX's Net Income Growth Rates IDXX's Ps Price to Sales ratio IDXX's Sales per Employee IDXX's Asset Turnover Ratio
IDXX's Net Margin IDXX's Pb Price to Book ratio IDXX's Financial Strength Ratios IDXX's Dividend Payout Ratio
Date modified: 2026-11-03T06:25:04+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2026Number of Employees Sep 30 2026
Phathom Pharmaceuticals Inc   740,919.14 $ 274.881  Million 371 
Intuitive Surgical Inc   711,803.07 $ 12,115.600  Million 17,021 
Johnson and Johnson  705,504.26 $ 99,335.000  Million 140,800 
Caredx Inc   650,190.85 $ 497.396  Million 765 
Organon and Co   611,100.00 $ 6,111.000  Million 10,000 
Butterfly Network Inc   562,340.91 $ 123.715  Million 220 
Bausch Health Companies Inc   547,438.42 $ 11,113.000  Million 20,300 
Iradimed Corporation  538,192.16 $ 89.340  Million 166 
Glaukos Corp  528,660.88 $ 578.355  Million 1,094 
Angiodynamics Inc   512,316.46 $ 323.784  Million 632 
Resmed Inc   505,115.57 $ 5,743.164  Million 11,370 
Avantor Inc   491,525.93 $ 6,635.600  Million 13,500 
Stryker Corp  469,642.86 $ 26,300.000  Million 56,000 
Dexcom Inc   459,900.90 $ 5,104.900  Million 11,100 
Medpace Holdings Inc   457,804.03 $ 2,838.385  Million 6,200 
Novocure Limited  451,955.14 $ 725.388  Million 1,605 
Omniab Inc   451,808.99 $ 40.211  Million 89 
Teladoc Health Inc   440,739.82 $ 2,468.143  Million 5,600 
Orthopediatrics Corp  437,981.73 $ 263.665  Million 602 
Vanda Pharmaceuticals Inc   430,165.10 $ 229.278  Million 533 
Axogen inc   429,141.48 $ 266.926  Million 622 
3m Company  417,305.79 $ 25,247.000  Million 60,500 
Bausch and Lomb Corp  416,769.23 $ 5,418.000  Million 13,000 
Cryo cell International Inc   409,559.89 $ 31.127  Million 76 
Brightspring Health Services Inc   403,367.83 $ 9,479.144  Million 23,500 
Repligen Corp  402,805.00 $ 805.610  Million 2,000 
Pro dex Inc   386,300.97 $ 79.578  Million 206 
Mimedx Group Inc   375,449.26 $ 303.363  Million 808 
Integra Lifesciences Holdings Corp  374,245.76 $ 1,656.786  Million 4,427 
Ge Healthcare Technologies Inc   368,111.11 $ 19,878.000  Million 54,000 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.